TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Merck to acquire Harpoon Therapeutics for $680m to strengthen oncology pipeline Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP)… byPallavi MadhirajuJanuary 9, 2024